| Tumor-associated macrophages and survival in classic Hodgkin's lymphoma C Steidl, T Lee, SP Shah, P Farinha, G Han, T Nayar, A Delaney, ... New England Journal of Medicine 362 (10), 875-885, 2010 | 1503 | 2010 |
| Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ... Nature 461 (7265), 809-813, 2009 | 1343 | 2009 |
| Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone NA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ... Journal of clinical oncology 30 (28), 3452-3459, 2012 | 1144 | 2012 |
| New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients D Haase, U Germing, J Schanz, M Pfeilstöcker, T Nösslinger, ... Blood, The Journal of the American Society of Hematology 110 (13), 4385-4395, 2007 | 1061 | 2007 |
| New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international … J Schanz, H Tüchler, F Solé, M Mallo, E Luno, J Cervera, I Granada, ... Journal of clinical oncology 30 (8), 820-829, 2012 | 879 | 2012 |
| Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival NA Johnson, KJ Savage, O Ludkovski, S Ben-Neriah, R Woods, C Steidl, ... Blood, The Journal of the American Society of Hematology 114 (11), 2273-2279, 2009 | 743 | 2009 |
| MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ... Nature 471 (7338), 377-381, 2011 | 716 | 2011 |
| The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ... Cell 167 (5), 1145-1149, 2016 | 547 | 2016 |
| Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ... Blood, The Journal of the American Society of Hematology 122 (7), 1256-1265, 2013 | 471 | 2013 |
| Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ... Journal of clinical oncology 33 (26), 2848-2856, 2015 | 460 | 2015 |
| Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment C Steidl, JM Connors, RD Gascoyne Journal of Clinical Oncology 29 (14), 1812-1826, 2011 | 460 | 2011 |
| Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ... Blood, The Journal of the American Society of Hematology 119 (9), 1963-1971, 2012 | 424 | 2012 |
| Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma R Rahal, M Frick, R Romero, JM Korn, R Kridel, F Chun Chan, B Meissner, ... Nature medicine 20 (1), 87-92, 2014 | 409 | 2014 |
| Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma D Ennishi, A Jiang, M Boyle, B Collinge, BM Grande, S Ben-Neriah, ... Journal of Clinical Oncology 37 (3), 190-201, 2019 | 380 | 2019 |
| Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ... Blood, The Journal of the American Society of Hematology 123 (13), 2062-2065, 2014 | 342 | 2014 |
| Cooperative epigenetic modulation by cancer amplicon genes L Rui, NCT Emre, MJ Kruhlak, HJ Chung, C Steidl, G Slack, GW Wright, ... Cancer cell 18 (6), 590-605, 2010 | 324 | 2010 |
| Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling AW Zhang, C O’Flanagan, EA Chavez, JLP Lim, N Ceglia, A McPherson, ... Nature methods 16 (10), 1007-1015, 2019 | 308 | 2019 |
| The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia A Kuendgen, M Schmid, R Schlenk, S Knipp, B Hildebrandt, C Steidl, ... Cancer 106 (1), 112-119, 2006 | 297 | 2006 |
| Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas KC Wiegand, AF Lee, OM Al‐Agha, C Chow, SE Kalloger, DW Scott, ... The Journal of pathology 224 (3), 328-333, 2011 | 282 | 2011 |
| Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition D Ennishi, K Takata, W Béguelin, G Duns, A Mottok, P Farinha, ... Cancer discovery 9 (4), 546-563, 2019 | 280 | 2019 |
